These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22077199)

  • 1. Interictal type 1 cannabinoid receptor binding is increased in female migraine patients.
    Van der Schueren BJ; Van Laere K; Gérard N; Bormans G; De Hoon JN
    Headache; 2012 Mar; 52(3):433-40. PubMed ID: 22077199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.
    Van Laere K; Goffin K; Bormans G; Casteels C; Mortelmans L; de Hoon J; Grachev I; Vandenbulcke M; Pieters G
    Arch Gen Psychiatry; 2009 Feb; 66(2):196-204. PubMed ID: 19188542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
    Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
    Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
    Van Laere K; Goffin K; Casteels C; Dupont P; Mortelmans L; de Hoon J; Bormans G
    Neuroimage; 2008 Feb; 39(4):1533-41. PubMed ID: 18077184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
    Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
    Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.
    Ceccarini J; Weltens N; Ly HG; Tack J; Van Oudenhove L; Van Laere K
    Transl Psychiatry; 2016 Jul; 6(7):e853. PubMed ID: 27404285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
    Gérard N; Pieters G; Goffin K; Bormans G; Van Laere K
    Biol Psychiatry; 2011 Oct; 70(8):777-784. PubMed ID: 21718968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positron emission tomographic study in spontaneous migraine.
    Afridi SK; Giffin NJ; Kaube H; Friston KJ; Ward NS; Frackowiak RS; Goadsby PJ
    Arch Neurol; 2005 Aug; 62(8):1270-5. PubMed ID: 16087768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.
    Ceccarini J; Casteels C; Koole M; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1582-94. PubMed ID: 23740372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB
    Ceccarini J; Ahmad R; Van de Vliet L; Casteels C; Vandenbulcke M; Vandenberghe W; Van Laere K
    J Nucl Med; 2019 Jan; 60(1):115-121. PubMed ID: 29934407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.
    Gérard N; Ceccarini J; Bormans G; Vanbilloen B; Casteels C; Goffin K; Bosier B; Lambert DM; Van Laere K
    J Mol Neurosci; 2010 Oct; 42(2):162-7. PubMed ID: 20182818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study.
    Ly HG; Ceccarini J; Weltens N; Bormans G; Van Laere K; Tack J; Van Oudenhove L
    Psychother Psychosom; 2015; 84(3):149-58. PubMed ID: 25833408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study.
    Kim JH; Kim S; Suh SI; Koh SB; Park KW; Oh K
    Cephalalgia; 2010 Jan; 30(1):53-61. PubMed ID: 19489887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
    Liu P; Lin LS; Hamill TG; Jewell JP; Lanza TJ; Gibson RE; Krause SM; Ryan C; Eng W; Sanabria S; Tong X; Wang J; Levorse DA; Owens KA; Fong TM; Shen CP; Lao J; Kumar S; Yin W; Payack JF; Springfield SA; Hargreaves R; Burns HD; Goulet MT; Hagmann WK
    J Med Chem; 2007 Jul; 50(15):3427-30. PubMed ID: 17608398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
    Casteels C; Lauwers E; Baitar A; Bormans G; Baekelandt V; Van Laere K
    Brain Res; 2010 Feb; 1316():153-62. PubMed ID: 20026090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex difference in brain CB1 receptor availability in man.
    Laurikainen H; Tuominen L; Tikka M; Merisaari H; Armio RL; Sormunen E; Borgan F; Veronese M; Howes O; Haaparanta-Solin M; Solin O; Hietala J;
    Neuroimage; 2019 Jan; 184():834-842. PubMed ID: 30296558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.
    Van Laere K; Koole M; Sanabria Bohorquez SM; Goffin K; Guenther I; Belanger MJ; Cote J; Rothenberg P; De Lepeleire I; Grachev ID; Hargreaves RJ; Bormans G; Burns HD
    J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
    Casteels C; Vanbilloen B; Vercammen D; Bosier B; Lambert DM; Bormans G; Van Laere K
    Synapse; 2010 Aug; 64(8):617-23. PubMed ID: 20340169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.